News Archive

Date: 05/23/2013
A new clinical trial is testing whether targeting treatments to a genetic anomaly can lead to better treatments for prostate cancer.
Date: 05/21/2013
Peripherally inserted central catheters have become many clinicians' go-to for IV delivery of antibiotics, nutrition, chemotherapy, and other medications, But compared to other central venous catheters (CVCs), these commonly-used catheters (known as PICCs) more than double the risk of dangerous blood clots - especially among patients who are critically ill or who have cancer, according to a new University of Michigan Health System study.
Date: 05/17/2013
With a focus on shared decision making between doctors and patients, more studies needed to determine how decision aids help guide choices for cancer screening.
Date: 05/10/2013
With a focus on shared decision making between doctors and patients, more studies needed to determine how decision aids help guide choices for cancer screeningWritten by: Beata Mostafavi. Media Inquiries: 734-764-2220, 8 a.m.-5 p.m.
Date: 05/08/2013
Written by: Laurel Thomas Gnagey. Media Inquiries: 734-647-1841, 8 a.m.-5 p.m. ET or ltgnagey@umich.edu
Date: 04/30/2013
Author, educator and grief counselor Alan Wolfelt, Ph.D. will help health professionals in the community better understand methods to address patient and co-worker grief at an address at the University of Michigan May 23, 2013.
Date: 04/15/2013
Cardiologists and oncologists will work together to prevent heart damage caused by cancer treatment a risk faced by as much as one-third of cancer patientsWritten by: Shantell Kirkendoll. Media Inquiries: 734-764-2220 8 a.m.-5 p.m. ET
Date: 04/11/2013
University of Michigan Comprehensive Cancer Center experts will discuss breast cancer risks (and how you can reduce yours), as well as screening, treatment and research at a free Breast Cancer Summit on Saturday, April 20, 2013 at Washtenaw Community College.
Date: 04/09/2013
One-quarter of women who should take hormone-blocking therapies as part of their breast cancer treatment either do not start or do not complete the five-year course, according to University of Michigan Comprehensive Cancer Center researchers.
Date: 04/03/2013
Large, international trial finds intermittent androgen deprivation is not equivalent to continuous treatment of prostate cancer.

Pages